An Interview with Dr. Enrique Caballero: Providing Culturally-Oriented Care to the Latinx Community
Meet Dr. A. Enrique Caballero: a Boston-based endocrinologist with decades of experience providing diabetes care to the Latinx community. After…
Connect1d Canada partners with the T1D Exchange
Connect1d Canada, a digital platform that allows those with type 1 diabetes (T1D) to easily learn about and participate in…
T1D Exchange Appoints Two New Members to its Board of Directors
T1D Exchange announced today the appointments of Dr. Margarita Ochoa-Maya and Dr. Kevin Larsen to its Board of Directors. Their…
A Parent’s Guide for Back-to-School with T1D
Life with diabetes can bring a lot of stress, but one of the most stressful events for parents and children…
Latest News on CGM and Dexcom Straight from the CEO, Kevin Sayer
T1D Exchange recently took advantage of the golden opportunity to interview Kevin Sayer, chairman, president and CEO of Dexcom. In…
The Latest from Viacyte, Dexcom and More at ADA
Scientific Sessions, or “Sci Sessions” for short, is the world’s largest meeting of the best and brightest researchers, health care…
T1D Exchange Research in the Spotlight at ADA
From June 25-29, 2021, the most brilliant minds in diabetes research gathered (virtually) for the American Diabetes Association’s (ADA) 81st…
Bigfoot Unity Cleared and Ready to Step Out: Interview with Jeffrey Brewer, CEO, Bigfoot Biomedical
On May 10, 2021 Bigfoot Biomedical Inc. received FDA Clearance for its Bigfoot Unity Diabetes Management System. Jeffrey Brewer is…
T1D Exchange Announces Two New Appointments to its Board of Directors
T1D Exchange Announces Two New Appointments to its Board of Directors April 14, 2021 T1D Exchange announced today the appointments of Gary A. Puckrein, Ph.D. and Phillip Cagnassola to its Board…
New T1D Equity Framework Partnership with Medtronic Inc.
